The two companies aren’t comparable on an apples-to-apples basis: BMY is a “pure” branded-drug company that derives a small proportion of sales from emerging markets, while PFE is a major player in branded generics and one of the premiere beneficiaries of The Global Demographic Tailwind.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”